Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.37 | 0.2 |
mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |